Re: Farmas USA
La razon de que se caliente ARIA en after ( 7,18$ )
Ever since Ariad Pharmaceuticals’ Ponatinib treatment for leukemia was given the green light by American regulator, the FDA, industry majors have been sniffing around. As its shares changed hands at $6.50, valuing the Massachusetts-based company at around £800m, dealers heard whispers from across the Pond that at least three international pharma groups including US giant Eli Lilly have made ‘friendly approaches’ to the Ariad board and are prepared to pay up to $20 a share in cash to gain control.
Re: Farmas USA
Re: Farmas USA
Re: Farmas USA
Veras tu los cortos mañana...
ARIA
Re: Farmas USA
ARIA
Felicidades a los afortunados. A mí hoy más me valdría no haber abierto la plataforma para nada. Hubiera ganado 1000 pavos en lugar de perder 700.
Voy a suicidarme un rato
Re: Farmas USA
Re: Farmas USA
a ver, que la cosa en after va aflojando, ya veremos mañana que pasa
ARIA